Skip to main content
Premium Trial:

Request an Annual Quote

UMBI Spins Out Proteomics Company

NEW YORK (GenomeWeb News) – The University of Maryland Biotechnology Institute said Monday that it has spun out a proteomics venture that will commercialize protein characterization and quantification technology.

The new Rockville-based company, called Omic Biosystems, will market a technology called DiART (deuterium (2H) isobaric amine reactive tags) that uses protein tagging designs coupled with sample preparation technology for use in large-scale mass spectrometry proteomics studies.

Omic Biosystems CEO and Co-founder Feng Tao said in a statement that the company will "help solve important bottleneck problems in the field of proteomics."

"The immediate market impact of this technology is its utility in biomarker discoveries," UMBI's Director of Technology Transfer and Commercialization, Jonathan Gottlieb, said in a statement. "Its broader impact will facilitate the translation of genomic and proteomic information into relevant clinical information that can be applied to new drug discovery and clinical diagnostics."

The DiART technology was developed at UMBI's Center for Advanced Research in Biotechnology in the lab of UMBI Assistant Professor and Omic Biosystems' Co-founder Shuwei Li.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.